Media
The Hartmann Report: Merith Mention on Trump’s MFN Deals
Merith Basey of Patients For Affordable Drugs said what’s needed is said what’s needed instead quote patients need systemic reforms that will lower drug prices.
News |
Media
The Hartmann Report: Merith Mention on Trump’s MFN Deals
Merith Basey of Patients For Affordable Drugs said what’s needed is said what’s needed instead quote patients need systemic reforms that will lower drug prices.
Media
IP Watchdog: Patient Advocate Groups Celebrate SCOTUS’ Denials of Pharma Challenges to IRA
That same day, several patient advocacy groups including Patients for Affordable Drugs and Public Citizen released public statements in support of the Supreme Court’s cert denials and launched a mobile billboard in Washington, D.C highlighting the Court’s decision.
Media
El Balad: FDA Chief: TrumpRx Marks Major Progress in Affordable Medication Access
Despite the optimism surrounding TrumpRx, skepticism exists among some patients. Sarah Wisniewski, a Maryland resident with multiple sclerosis, expressed doubts. She has faced challenges securing coverage for necessary medications, raising concerns about whether the program can effectively address the needs of patients like her.
Media
Bloomberg: Trump Drug Pricing Order Spurs Doubts With Staff Cuts, Tariffs
But Merith Basey, executive director of Patients For Affordable Drugs, said in a statement that the change wouldn’t lower costs, but “hand drug companies four additional years to price-gouge patients.”
Media
Patients Urge Drug Companies To Stop Attempts To Block Lower Negotiated Prices From Taking Effect WASHINGTON, D.C. — Patients For Affordable Drugs, alongside patient advocates and allies including Public Citizen, Social Security Works, and SPACEs in Action, gathered in Washington, D.C. to demand drug companies drop their lawsuits aimed at blocking Medicare from negotiating lower drug prices […]